Expression of CR1/2 receptor on alloantigen-stimulated mouse T cells

Z. Qian, J. G. Bieler, W. M. Baldwin, B. A. Wasowska

Research output: Contribution to journalArticle

Abstract

Antibodies can mediate injury of organ transplants by several mechanisms, including complement activation and interaction with Fc receptors on cells. We tested the hypothesis that antibodies could also cause up-regulation of complement receptors on cells to increase the responses to complement activation by interaction with split products of C3. In our experimental model, B10.A (H-2a) cardiac transplants survive significantly longer in C57BL/6 (H-2b) immunoglobulin knockout recipients (IgKO) than in their wild-type counterparts. Passive transfer of specific antibodies to donor MHC class I to IgKO recipients of cardiac allografts at the time coinciding with a vigorous cellular infiltration reconstituted acute rejection. We tested the effects of alloantibodies on CR1/2 expression by alloantigen-stimulated T cells. Both CD4+/CR1/2+ and CD8+/CR1/2+ populations of T cells were expanded in C57BL/6 splenocytes stimulated by B10.A alloantigen in 7-day MLR after coculture with endothelial cells sensitized with IgG1 and IgG2b mAb specific to MHC. Endothelial cells sensitized with antibodies also caused an expansion of CD8+ T cells expressing CR1/2 in lymph node lymphocytes harvested from a C57BL/6 recipient of a B10.A cardiac allograft. These data suggest that antibodies can augment the cellular rejection process through expanding the population of T cells interacting with complement split products.

Original languageEnglish (US)
Pages (from-to)32-34
Number of pages3
JournalTransplantation proceedings
Volume37
Issue number1
DOIs
StatePublished - Jan 1 2005

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this